Results 81 to 90 of about 5,463 (146)

Updates in the management of newly diagnosed chronic lymphocytic leukemia. [PDF]

Hematology Am Soc Hematol Educ Program
McClellan K, Sitlinger A.
europepmc   +1 more source

Successful Therapy with Obinutuzumab in a Toddler with Primary Multidrug-Resistant Nephrotic Syndrome. [PDF]

J Clin Med
Drozynska-Duklas M, Zagozdzon I, Chudzik I, Balasz-Chmielewska I, Kranz A, Zurowska A.   +5 more
europepmc   +1 more source

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Trillini M, Portalupi V, Gennarini A, Surdi L, Currado A, Marasà M, Podestà MA, Villa A, Peracchi T, Fidone D, Rubis N, Diadei O, Guarinoni C, Casiraghi F, Todeschini M, Cugini D, Carrara F, Martinetti D, Rizzo P, Remuzzi G, Ruggenenti P.   +20 more
europepmc   +1 more source

Daratumumab for Treatment of Refractory Podocytopathy: A Case Report. [PDF]

Kidney Med
Curto A, Martinez Leon VJ, Geara AS.
europepmc   +1 more source

Nanomechanical and Thermodynamic Alterations of Red Blood Cells in Chronic Lymphocytic Leukemia: Implications for Disease and Treatment Monitoring. [PDF]

Int J Mol Sci
Strijkova V, Katrova V, Ivanova M, Langari A, Gartcheva L, Guenova M, Alexandrova-Watanabe A, Taneva SG, Krumova S, Todinova S.   +9 more
europepmc   +1 more source

Triplet regimens for frontline treatment of CLL-Great company or just a crowd? [PDF]

Hemasphere
McKeague S, Seymour JF.
europepmc   +1 more source

Clinical practice guidelines for the diagnosis and management of chronic lymphocytic leukemia in Saudi Arabia: consensus statement by an expert panel. [PDF]

Front Med (Lausanne)
Alotaibi G, Aleem A, Absi A, Alaskar AS, Alfraih F, Alhejazi A, Almasari A, Alzahrani MF, Motabi I, El Fakih R.   +9 more
europepmc   +1 more source

Novel Sequential Therapy with Obinutuzumab and Telitacicept in Severe Lupus Nephritis with Glucocorticoid-Induced Avascular Necrosis (AVN) of the Femoral Head: A Case Report. [PDF]

Am J Case Rep
Zhang Y, Huang L, Li N, Zeng X, Zheng Z, Wang X, Zhang Y, Tang C.   +7 more
europepmc   +1 more source

Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy. [PDF]

Kidney Int Rep
Atay İ, Eröz E, Heybeli C.
europepmc   +1 more source

Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]

Front Immunol
Wu C, Wang Y, Chen S, Lin Y, Du F, Wang X, Chen S, Lu L, Ye S, Ding H, Fu Q.   +10 more
europepmc   +1 more source